Success Metrics

Clinical Success Rate
100.0%

Based on 1 completed trials

Completion Rate
100%(1/1)
Active Trials
2(50%)
Results Posted
0%(0 trials)

Phase Distribution

Ph not_applicable
4
100%

Phase Distribution

0

Early Stage

0

Mid Stage

0

Late Stage

Phase Distribution4 total trials
N/ANon-phased studies
4(100.0%)

Highest Phase Reached

Unknown

Trial Status & Enrollment

Completion Rate

100.0%

1 of 1 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

2

trials recruiting

Total Trials

4

all time

Status Distribution
Active(2)
Completed(1)
Other(1)

Detailed Status

Recruiting2
unknown1
Completed1

Development Timeline

Analytics

Development Status

Total Trials
4
Active
2
Success Rate
100.0%
Most Advanced
N/A

Trials by Phase

N/A4 (100.0%)

Trials by Status

unknown125%
recruiting250%
completed125%

Recent Activity

2 active trials
Showing 4 of 4
recruitingnot_applicable

OCT-Guided Stent Optimization for Short-Duration Dual Antiplatelet Therapy in Stable Angina

NCT07198529
recruitingnot_applicable

OPT-CAD Score GUIded Dual ANtiplatelet De-esCalation Time

NCT06216821
completednot_applicable

Evaluation of a Modified Anti-Platelet Therapy Associated With Low-dose DES Firehawk in Acute Myocardial Infarction Patients Treated With Complete Revascularization Strategy

NCT04753749
unknownnot_applicable

Ticagrelor Monotherapy in PAtients Treated With New-generation Drug-eluting Stents for Acute Coronary Syndrome; T-PASS Trial

NCT03797651

Clinical Trials (4)

Showing 4 of 4 trials
NCT07198529Not Applicable

OCT-Guided Stent Optimization for Short-Duration Dual Antiplatelet Therapy in Stable Angina

Recruiting
NCT06216821Not Applicable

OPT-CAD Score GUIded Dual ANtiplatelet De-esCalation Time

Recruiting
NCT04753749Not Applicable

Evaluation of a Modified Anti-Platelet Therapy Associated With Low-dose DES Firehawk in Acute Myocardial Infarction Patients Treated With Complete Revascularization Strategy

Completed
NCT03797651Not Applicable

Ticagrelor Monotherapy in PAtients Treated With New-generation Drug-eluting Stents for Acute Coronary Syndrome; T-PASS Trial

Unknown

All 4 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
4